U.S. Physical Therapy Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" U.S. Physical Therapy stock.
View analyst ratings for U.S. Physical Therapy or view top-rated stocks.

Wall Street analysts have given U.S. Physical Therapy a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but U.S. Physical Therapy wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for U.S. Physical Therapy.

U.S. Physical Therapy will be holding an earnings conference call on Thursday, August 5th at 10:30 AM Eastern. Interested parties can register for or listen to the call using this link.

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, May, 6th. The company reported $0.64 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.47 by $0.17. The firm had revenue of $112.37 million for the quarter, compared to analyst estimates of $110.36 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 14.19% and a net margin of 7.73%. The company's quarterly revenue was down .3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.30 earnings per share.
View U.S. Physical Therapy's earnings history.

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, USPH shares have increased by 26.3% and is now trading at $117.74.
View which stocks have been most impacted by COVID-19.

U.S. Physical Therapy declared a quarterly dividend on Thursday, May 6th. Shareholders of record on Friday, May 14th will be paid a dividend of $0.35 per share on Friday, June 11th. This represents a $1.40 annualized dividend and a dividend yield of 1.19%. The ex-dividend date of this dividend is Thursday, May 13th.
View U.S. Physical Therapy's dividend history.

U.S. Physical Therapy pays an annual dividend of $1.40 per share and currently has a dividend yield of 1.20%. U.S. Physical Therapy does not yet have a strong track record of dividend growth. The dividend payout ratio of U.S. Physical Therapy is 46.82%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 46.98% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

U.S. Physical Therapy updated its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share guidance of 2.680-2.780 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.56. The company issued revenue guidance of -.

2 analysts have issued 12 month target prices for U.S. Physical Therapy's shares. Their forecasts range from $130.00 to $135.00. On average, they anticipate U.S. Physical Therapy's share price to reach $132.50 in the next year. This suggests a possible upside of 12.5% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy or view top-rated stocks among Wall Street analysts.

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Encompass Health (EHC), Tenet Healthcare (THC), Acadia Healthcare (ACHC), Select Medical (SEM), The Ensign Group (ENSG), Petco Health and Wellness (WOOF), Community Health Systems (CYH), Brookdale Senior Living (BKD), National HealthCare (NHC), Five Star Senior Living (FVE) and Capital Senior Living (CSU).
View all of USPH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional shareholders include Scout Investments Inc. (0.74%), Aptus Capital Advisors LLC (0.14%), State of Alaska Department of Revenue (0.07%) and Albert D Mason Inc. (0.05%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy.

USPH stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., and Albert D Mason Inc.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Edward L Kuntz, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy or view top insider-selling stocks.

USPH stock was bought by a variety of institutional investors in the last quarter, including Aptus Capital Advisors LLC, and State of Alaska Department of Revenue. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy or or view top insider-buying stocks.

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of USPH stock can currently be purchased for approximately $117.74.

U.S. Physical Therapy has a market capitalization of $1.52 billion and generates $422.97 million in revenue each year. The company earns $35.19 million in net income (profit) each year or $2.99 on an earnings per share basis.

U.S. Physical Therapy employs 4,630 workers across the globe.

The official website for U.S. Physical Therapy is www.usph.com.

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]